Drug
Avacopan
Avacopan: highest development phase Post-Market, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Avacopan NCT06072482 | Post-Market | Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
Latest
No recent events.
Follow Avacopan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.